Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol Myers-AstraZeneca Diabetes Drug Delayed by U.S. FDA
Bloomberg
Wednesday, October 26, 2011 - 6:12pm
tags:
Bristol-Myers Squibb, diabetes, FDA, AstraZeneca, Dapagliflozin
Biotech 2011: Teva, Merck directors share views of biopharma industry
Med City
Wednesday, October 26, 2011 - 11:07am
tags:
Teva Pharmaceuticals, Merck, Biotech 2011
Mylan says CEO Coury to step down; shares rise
Reuters
Wednesday, October 26, 2011 - 11:04am
tags:
Mylan, Pharma CEOs, Robert Coury
Merck KGaA Advances Most Since 2009 as Profit Beats Estimates
Bloomberg
Wednesday, October 26, 2011 - 10:41am
tags:
Merck KGaA, earnings
Shire pump bypasses hurdle to sneak enzyme drug into brain
Fierce Drug Delivery
Wednesday, October 26, 2011 - 10:38am
tags:
Shire, Hunter Syndrome, Elaprase
Bayer and new partner Onyx crow over PhIII regorafenib success
Fierce Biotech
Wednesday, October 26, 2011 - 10:30am
tags:
regorafenib, ONYX Pharmaceuticals, Bayer, colon cancer
LABA Asthma drugs may increase attacks in kids: report
Reuters
Wednesday, October 26, 2011 - 10:29am
tags:
LABAs, long acting beta agonists, asthma, GSK, Serevent, Merck, Foradil, corticosteroids
3 Biotech Takeover/LBO Targets With Bullish Short Trends
Seeking Alpha
Wednesday, October 26, 2011 - 10:25am
tags:
M&A, Alnylam, Seattle Genetics, Exelixis
Allergan Shares Drop After Profit Forecast Missed Estimate
Bloomberg
Wednesday, October 26, 2011 - 10:18am
tags:
Allergan, earnings
Glaxo Third-Quarter Earnings Match Estimates
Bloomberg
Wednesday, October 26, 2011 - 9:13am
tags:
earnings, GSK
Biogen readies its app after BG-12 beats Copaxone in PhIII MS study
Fierce Biotech
Wednesday, October 26, 2011 - 9:11am
tags:
Teva Pharmaceuticals, multiple sclerosis, MS, Copaxone, Biogen, BG-12
Amgen Is Poised For Continued Success
Seeking Alpha
Wednesday, October 26, 2011 - 9:08am
tags:
Amgen, Pharmasset, Dendreon
Evaluating Abbott Labs: Just How Do You Formulate Cash Flow?
Seeking Alpha
Wednesday, October 26, 2011 - 9:07am
tags:
Abbott Laboratories, cash
Abbott Labs: Genes Aren't The Only Thing That Can Effectively Be Spliced
Seeking Alpha
Wednesday, October 26, 2011 - 9:06am
tags:
Abbott Laboratories, Bardoxolone, daclizumab
Human Genome Bungles Benlysta
TheStreet.com
Wednesday, October 26, 2011 - 9:05am
tags:
Human Genome Sciences, Benlysta, lupus
FTC pay-for-delay study flawed?
Patent Baristas
Tuesday, October 25, 2011 - 6:37pm
tags:
FTC, pay-for-delay, antitrust
FDA approves Lundbeck's Onfi for LGS
Pharma Times
Tuesday, October 25, 2011 - 6:31pm
tags:
Lundbeck, LGS, FDA, Onfi, epilepsy
Pradaxa May Not Stop A Different Type Of Bleeding
Pharmalot
Tuesday, October 25, 2011 - 6:29pm
tags:
Boehringer Ingelheim, Pradaxa
Highflying Questcor Expected To Report 71% Sales Jump
Investors.com
Tuesday, October 25, 2011 - 1:49pm
tags:
earnings, Questcor
Amgen Says it Set Aside $780 Million to Settle Drug Sale Kickback Claims
Bloomberg
Tuesday, October 25, 2011 - 12:38pm
tags:
kickbacks, Amgen, Aranesp

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.